Today, the Advisory Committee on Immunization Practices (ACIP) voted to recommend a preference for using the nasal spray flu vaccine (i.e., LAIV) instead of the flu shot (i.e., IIV) in healthy children 2-8 years of age when it is immediately available. ACIP is a panel of immunization experts that advises the Centers for Disease Control and Prevention (CDC).
This article originally appeared here: https://tools.cdc.gov/api/embed/downloader/download.asp?m=132608&c=308626. The source website for this article is CDC Newsroom Feed.
The original publication date for this article is June 25, 2014 4:00 pm